SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-22-001842
Filing Date
2022-02-24
Accepted
2022-02-24 07:39:19
Documents
62
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20211231x6k.htm 6-K 21697
2 EX-99.1 tmb-20211231xex99d1.htm   iXBRL EX-99.1 916096
3 EX-99.2 tmb-20211231xex99d2.htm EX-99.2 512913
  Complete submission text file 0001558370-22-001842.txt   4231993

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20211231.xsd EX-101.SCH 49967
5 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 42231
6 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 131454
7 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 308710
8 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 223708
56 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231xex99d1_htm.xml XML 482634
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 22666550
SIC: 2834 Pharmaceutical Preparations